Candriam SCA’s Axon Enterprise AXON Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.59M Buy
6,402
+324
+5% +$136K 0.02% 435
2026
Q1
$2.58M Hold
6,078
0.01% 473
2025
Q4
$3.45M Buy
6,078
+234
+4% +$145K 0.02% 430
2025
Q3
$4.19M Buy
5,844
+128
+2% +$97.1K 0.02% 396
2025
Q2
$4.73M Sell
5,716
-118
-2% -$80.3K 0.03% 361
2025
Q1
$3.07M Buy
5,834
+24
+0.4% +$14K 0.02% 423
2024
Q4
$3.45M Buy
5,810
+641
+12% +$349K 0.02% 413
2024
Q3
$2.07M Buy
5,169
+113
+2% +$39K 0.01% 495
2024
Q2
$1.49M Buy
5,056
+643
+15% +$192K 0.01% 532
2024
Q1
$1.38M Hold
4,413
0.01% 562
2023
Q4
$1.14M Buy
4,413
+425
+11% +$95.8K 0.01% 568
2023
Q3
$794K Hold
3,988
0.01% 585
2023
Q2
$778K Sell
3,988
-713
-15% -$148K 0.01% 636
2023
Q1
$973K Buy
+4,701
New +$935K 0.01% 701

Other funds holding AXON

Candriam SCA's AXON Position: Q2 2026 in Review

Candriam SCA increased its Axon Enterprise (AXON) stake by 5.3% in Q2 2026, buying an estimated $136K and bringing the position to 6,402 shares worth $3.59M. The position accounts for 0.02% of the portfolio, ranked #435.

Candriam SCA first reported a position in AXON in Q1 2023 and has held it in 14 quarters since. The position peaked at $4.73M in Q2 2025. 1,120 funds tracked by Wall St. Rank hold AXON as of Q2 2026.

  • Candriam SCA held 6,402 shares of Axon Enterprise worth $3.59M as of Q2 2026.
  • Candriam SCA bought 324 Axon Enterprise shares in Q2 2026, an estimated $136K.
  • Axon Enterprise made up 0.02% of Candriam SCA's portfolio in Q2 2026, its #435 holding.
  • Candriam SCA first reported a position in Axon Enterprise in Q1 2023 and has held it in 14 quarters since.
  • Candriam SCA's Axon Enterprise position peaked at $4.73M in Q2 2025.
  • 1,120 funds tracked by Wall St. Rank held Axon Enterprise as of Q2 2026.

Based on Candriam SCA's 13F filing for Q2 2026, filed 13 Aug 2026.